NanoViricides
NNVC
#10132
Rank
โ‚ฌ19.01 M
Marketcap
1,06ย โ‚ฌ
Share price
0.82%
Change (1 day)
-23.40%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of June 2025 : โ‚ฌ6.45 Million

According to NanoViricides's latest financial reports the company has โ‚ฌ6.45 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$โ‚ฌ10.67 M-21.59%
2023-06-30$โ‚ฌ13.61 M-38.18%
2022-06-30$โ‚ฌ22.02 M-12.67%
2021-06-30$โ‚ฌ25.22 M30.27%
2020-06-30$โ‚ฌ19.36 M107.61%
2019-06-30$โ‚ฌ9.32 M-38.2%
2018-06-30$โ‚ฌ15.09 M-15.25%
2017-06-30$โ‚ฌ17.8 M-14.18%
2016-06-30$โ‚ฌ20.75 M-27.3%
2015-06-30$โ‚ฌ28.54 M67.27%
2014-06-30$โ‚ฌ17.06 M177.29%
2013-06-30$โ‚ฌ6.15 M-43.75%
2012-06-30$โ‚ฌ10.94 M55.96%
2011-06-30$โ‚ฌ7.01 M34.61%
2010-06-30$โ‚ฌ5.21 M196.51%
2009-06-30$โ‚ฌ1.75 M523.78%
2008-06-30$โ‚ฌ0.28 M-24.31%
2007-06-30$โ‚ฌ0.37 M-61.93%
2006-06-30$โ‚ฌ0.97 M-1868.1%
2005-06-30$-โ‚ฌ0.06 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ0.34 Billion-5,259.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚ฌ0.14 Billion-2,184.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ18.42 B 285,311.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ15.97 B 247,320.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ44.58 B 690,375.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ18.18 B 281,586.77%๐Ÿ‡ฌ๐Ÿ‡ง UK